|
|
Vaccine Detail
|
Corynebacterium parvum, DTIC |
| Vaccine Information |
- Vaccine Name: Corynebacterium parvum, DTIC
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: bacterial cell
- Status: Research
- Preparation: Nonspecific immunotherapy with monthly intramuscular (IM) injections (Clunie et al., 1980).
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
Human Response
- Vaccine Immune Response Type: VO_0003057
- Immune Response: a fall in T-cell counts and a rise in anti-C parvum antibodies were seen in patients receiving C parvum, but these changes did not reach the 5% level of significance when compared with the group undergoing chemotherapy alone (Clunie et al., 1980).
|
| References |
Clunie et al., 1980: Clunie GJ, Gough IR, Dury M, Furnival CM, Bolton PM. A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results. Cancer. 1980; 46(3); 475-479. [PubMed: 6994866].
|
|
